Stock Rich List
Nasdaq: REGN

Regeneron Pharmaceuticals insiders

The officers, directors and 10% owners of Regeneron Pharmaceuticals, Inc. who hold the most stock, valued at the live REGN price.

$923.34
REGN today −$22.2M (−2.35%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
18
Their REGN stock
$3.80B
Market value
$95.52B
Held by ranked insiders
3.98%

Insiders by value of REGN holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Leonard S. SchleiferBd. Co-Chair, President & CEO2,398,771$2.21B2.32%141st
2George YancopoulosBd. Co-Chair, President & CSO925,945$855M0.90%312th
3P. Roy VagelosDirector467,104$431M0.45%529th
4Neil E. StahlEVP Research and Development59,283$54.7M<0.1%2374th
5Andrew MurphyCo-Chief Scientific Officer51,193$47.3M<0.1%2647th
6Joseph LaRosaEVP General Counsel and Secret48,128$44.4M<0.1%2766th
7Daniel P. Van PlewEVP & General Mgr, Industrial35,178$32.5M<0.1%3545th
8George L. SingDirector25,297$23.4M<0.1%4625th
9Christopher R. FenimoreEVP Finance CFO25,224$23.3M<0.1%4637th
10Robert E. LandryEVP Finance CFO23,963$22.1M<0.1%4735th
11Arthur F. RyanDirector17,303$16.0M<0.1%6117th
12Michael S. BrownDirector12,865$11.9M<0.1%7716th
13Marion McCourtEVP Commercial10,524$9.7M<0.1%8972nd
14Joseph L. GoldsteinDirector6,703$6.2M<0.1%12489th
15Christine A. PoonDirector5,219$4.8M<0.1%7643rd
16Marc Tessier-LavigneDirector2,434$2.2M<0.1%3118th
17Bonnie L. BasslerDirector1,703$1.6M<0.1%11424th
18David P. SchenkeinDirector603$557K<0.1%6200th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Regeneron Pharmaceuticals; see each profile for the filing.